The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Viatris Healthcare LimitedEU/1/13/866/001-002

Main Information

Trade NameCholib
Active SubstancesMicronized fenofibrate
Simvastatin with 0.2% butylated hydroxyanisole (bha), (E320)
Dosage FormFilm-coated tablet
Licence HolderViatris Healthcare Limited
Licence NumberEU/1/13/866/001-002

Group Information

ATC CodeC10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA04 simvastatin and fenofibrate


License statusAuthorised
Licence Issued26/08/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back